SCHEMBL7980036

SCHEMBL7980036

COc1cc2c(nc(N)c3cncn32)c(-c2c(F)cccc2Cl)c1NCCN1CCOCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 8/20 0.54
PDPK1 O15530 1/20 0.42
LMNA P02545 4/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 2/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.38
ALDH1A1 P00352 1/20 0.38
ATM Q13315 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
SUV39H2 Q9H5I1 1/20 0.38
MAPK8 P45983 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
HIF1A Q16665 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984582 0.92 LCK (0.61) LCKPDPK1LMNASMN1; SMN2HSD17B10
SCHEMBL7981100 0.84 LCK (0.58) LCKSMN1; SMN2CSF1R
SCHEMBL7983616 0.84 LCK (0.51) LCKLMNAHSD17B10KDM4EALDH1A1
SCHEMBL7980019 0.79 LCK (0.52) LCKSMN1; SMN2MAPTL3MBTL1
SCHEMBL7983651 0.79 LCK (0.59) LCKPDPK1LMNAHSD17B10KDM4E
SCHEMBL7982990 0.77 LCK (0.55) LCKPDPK1
SCHEMBL7983111 0.76 LCK (0.58) LCK
SCHEMBL7983212 0.74 LCK (0.60) LCKL3MBTL1
SCHEMBL4041190 0.74 LCK (0.51) LCKPDPK1LMNAHSD17B10KDM4E
SCHEMBL7987022 0.73 LCK (0.52) LCKPDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed